Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
Authors:
Open Access
- 1 February 2021
- journal article
- review article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 6 (2) , 106-119
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
This publication has 163 references indexed in Scilit:
- High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North CameroonPLOS ONE, 2013
- Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based StudyPLOS ONE, 2013
- Chronic HBV infection among pregnant women and their infants in Shenyang, ChinaVirology Journal, 2013
- A Multicentre Molecular Analysis of Hepatitis B and Blood-Borne Virus Coinfections in Viet NamPLOS ONE, 2012
- Hepatitis B virus genotypes and precore and core mutants in UAE patientsVirology Journal, 2010
- Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference unitsHepatology International, 2010
- Epidemiological and Clinical Features of Hepatitis B Virus Genotypes among Immigrants in Southern ItalyHepatitis Research and Treatment, 2010
- Characteristics of treatment naive chronic hepatitis B in Bangladesh: Younger populations are more affected; HBeAg-negatives are more advancedSaudi Journal of Gastroenterology, 2008
- Non-A Hepatitis B Virus Genotypes in Antenatal Clinics, United KingdomEmerging Infectious Diseases, 2007
- The association of complex liver disorders with HBV genotypes prevalent in PakistanVirology Journal, 2007